BSE: 524506 - Coral Laboratories Limited

Rentabilidade por seis meses: -19.84%
Rendimento de dividendos: +0.23%

Cronograma de promoção Coral Laboratories Limited


Sobre a empresa Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

mais detalhes
The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.23
Дивиденд ао 2
Сайт http://corallab.com
Цена ао 757.6
Alteração de preço por dia: -2.54% (747.35)
Alteração de preço por semana: -1.55% (739.8)
Alteração de preço por mês: -9.81% (807.6)
Alteração de preço em 3 meses: -4.44% (762.2)
Mudança de preço em seis meses: -19.84% (908.6)
Mudança de preço por ano: +93.76% (375.9)
Mudança de preço em 3 anos: +114.98% (338.8)
Mudança de preço em 5 anos: +432.03% (136.9)
Mudança de preço desde o início do ano: -1.71% (741)

Subestimação

Nome Significado Nota
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
EV/EBITDA 0 0
Total: 8

Eficiência

Nome Significado Nota
ROA, % 8.31 3
ROE, % 9.5 3
Total: 2

Dividendos

Nome Significado Nota
Div yield, % 0.23 0.58
DSI 0.9286 9.29
Total: 1.91

Obrigação

Nome Significado Nota
Debt/EBITDA 0 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 16.32 3
Rentabilidade Ebitda, % 0 5
Rentabilidade EPS, % 121.44 10
Total: 7.6

Supervisor Cargo Pagamento Ano de nascimento
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 ano)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 anos)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

Endereço: India, Mumbai, #3B Patanwala Industrial Estate - abrir no Google Maps, abrir mapas Yandex
Site: http://corallab.com